Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis.
about
Statins for primary cardiovascular prevention in the elderlyPattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?Statins in Primary Prevention: Uncertainties and Gaps in Randomized Trial Data.A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in womenRecent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent.The JUPITER lipid lowering trial and vitamin D: Is there a connection?Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating RosuvastatiBias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspectiveThe timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy.Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner.Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.Medical management of stable coronary atherosclerosis.Prevention of diseases after menopause.Dyslipidemia and cardiovascular disease in women.Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.Women Versus Men: Is There Equal Benefit and Safety from Statins?Hormone-replacement therapy: current thinking.Statin prescribing according to gender, age and indication: what about the benefit-risk balance?Meta-Analyses of Statin Therapy for Primary Prevention Do Not Answer Key Questions: An Empirical Appraisal of 5 Years of Statin Meta-Analyses.Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece.Sex differences in independent factors associated with coronary artery disease.Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.Results from the CLUES study: a cluster randomized trial for the evaluation of cardiovascular guideline implementation in primary care in Spain.Effect of an increased dosage of statins on spinal degenerative joint disease: a retrospective cohort study.Increased cardiovascular and renal disease but not reduced life expectancy among diabetic participants in the general Northern Greek population.Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysisConsiderable uncertainty remains in the evidence for primary prevention of cardiovascular disease
P2860
Q26783401-1DBD2818-D922-44C0-8907-F222270D6786Q28541300-4542293C-E58A-4C16-B7E5-2C842977D3A4Q31133434-BB6FD7F9-8400-47CC-BBAE-4F65C9D614F8Q33634188-78AB2A7E-4AC2-4D72-861F-D87630E56994Q34536800-A081FA9F-A84F-49FC-8755-84FC425F7E49Q34612394-3FC328BA-47F8-4A27-962C-28B2018173E6Q34847190-AB1AAC79-422F-452D-A930-95FB2EF05D23Q35631575-9DE9744B-54AE-46D4-819A-D0D14847829EQ35734332-C41E55C7-D488-428C-A0D8-74ECFC05B7E7Q36082805-A2F99234-A204-49A4-AF2C-A1335FC2B231Q36781520-176318AD-D408-4405-BD28-2E9DA05246E3Q36863876-A93F5D22-ADDC-4803-99C2-8ED915EFE9D9Q37227150-B909FA18-97A1-4CE8-A945-780D2E2115C8Q37662217-743E5E1E-669A-431D-86CB-A0BF6951BBB6Q38083007-FE13BECE-E7EA-4230-86E1-5B5A50654DD5Q38223587-94F90DA7-77FE-4CE7-B57B-E89C7CB900AFQ38508952-03419640-7848-4114-83A7-7BB3F74242C2Q38626233-17EDD180-B4E1-4899-88F3-B581760B4F06Q38702257-5EC49690-D696-4F8B-BDBD-63C3A32C3E95Q38975101-DA6D6BDF-5E4E-4F44-982B-8E62B6FBB9A8Q40455288-97EA83BB-4B43-4F7C-BE17-66B4197271A2Q40769604-6347EAFC-9675-47D3-9D38-0C6BC0B7285BQ43484384-0917488B-7B2C-4C1C-8C5E-6F8B175A843EQ43808557-AC517E80-AADA-48B0-B213-658BDE1D8DE4Q47109312-6FE2F1AB-52E1-4E70-BF09-B01B5F9C60B9Q49225560-B600DDD3-4751-4BF4-852B-5ADEFFBF41E6Q50036065-DEE80A65-4BC0-46A6-994B-9C676BDB30F1Q50062355-9057E7A4-7405-4E91-91AA-672F12496714Q57618849-2F2D2F0B-25DB-4292-AA04-8F32CC866303Q57691356-30FB5BA8-0893-468F-888D-E67238B04469
P2860
Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@ast
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@en
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@nl
type
label
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@ast
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@en
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@nl
prefLabel
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@ast
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@en
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@nl
P2093
P1476
Impact of gender in primary pr ...... atin therapy: a meta-analysis.
@en
P2093
Massimo Chiariello
Pasquale Perrone-Filardi
Pierluigi Costanzo
P356
10.1016/J.IJCARD.2008.08.001
P577
2008-09-14T00:00:00Z